About one in eight Americans take GLP-1 weight loss drugs, which have also been shown to lower the risk of heart attacks, strokes, kidney disease, and liver inflammation, and reduce cravings.
Dr. Melanie Jay, director of the New York University Langone Comprehensive Program on Obesity, joins us to discuss what we know about GLP-1s.
This article was originally published on WBUR.org.
Copyright 2026 WBUR
